auto_awesome
Tracking this entity every week?
Watch this entity, get an email digest the moment they win, lose, or are recompete-eligible. Free on every plan.
including delayed or cumulative effects of past treatments or risk factor values
SaveTotal Grants
2
Total Amount
$0
Provinces Served
1
Top Recipients by Funding Amount
| # | Recipient | Grants | Total Amount |
|---|---|---|---|
| 1 | as well as in the laboratory tests and biomarkers of disease progression | 2 | $0 |
Geographic Distribution by Province
| Province / Territory | Grants | Total Amount | Share |
|---|---|---|---|
| disease recurrence | 2 | $0 | 0% |
Recent Grants
Recipient
Amount
Year
Purpose
as well as in the laboratory tests and biomarkers of disease progression
--
--
as well as in the laboratory tests and biomarkers of disease progression
--
--
as well as in the laboratory tests and biomarkers of disease progression
----
whereas an anti-hypertensive treatment will affect the patient’s current blood pressure
as well as in the laboratory tests and biomarkers of disease progression
----
whereas an anti-hypertensive treatment will affect the patient’s current blood pressure
Explore More Government Data
IT Spending by Department
Federal technology budgets and consulting spend trends
Departmental Budgets
Budget breakdowns for every federal department and agency
Federal Contracts
Search 1.3M+ government contracts from the Open Government Portal
Contract Awards
Track who wins government contracts and award patterns
Standing Offers
Browse TBIPS, ProServices, and other procurement vehicles
Buy Canadian Policy
Guide to the 2025-2026 domestic procurement policy
Indigenous Procurement
PSAB, mandatory set-asides, and the 5% target